A treatment for eye diseases that is derived from human embryonic stem cells might have improved the vision of two patients, bolstering the beleaguered field, researchers reported Monday. Dr. Steven Schwartz, a retina specialist at the University of California, Los Angeles, conducted the trial with two patients. Sue Freeman said her vision improved in a meaningful way after the treatment, which used embryonic stem cells. The report, published online in the medical journal The Lancet, is the first to describe the effect on patients of a therapy involving human embryonic stem cells. The paper comes two months after the Geron...